AbbVie, Genmab Post Trial Setback for Lymphoma Drug (ABBV:NYSE)

연합뉴스-Yonhap News Agency

Lean Right

Factuality

Ownership

(Seoul = Yonhap News) Reporter Kim Young-shin = The government [plans] to conduct clinical trials for cell therapy targeting patients with advanced hepatocellular carcinoma and diffuse large B-cell lymphoma (DLBCL)...

조선일보

Lean Right

Factuality

Ownership

Immunotherapy treatments for patients with advanced liver cancer and hematological cancers at high risk of recurrence have passed government clinical review. Research to verify the potential for new treatments for patients for whom existing standard therapies have been insufficient is expected to begin in earnest. On the 23rd, the Ministry of Health and Welfare held the '8th Advanced Regenerative Medicine and Advanced Biopharmaceutical Review Co…